In this interview, we spoke with Steven Cramer about regenerative stroke therapies, including the challenges involved with bringing these into the clinic.
Browsing: regenerative medicine
After careful evaluation of the ‘Right to Try ‘Act, BrainStorm have announced that it will not make NurOwn® available under this legislation at this time.
Discover the emerging field of biomaterials in regenerative strategies for spinal cord injury in this editorial Future Science OA.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
Neuroregeneration: pipelines, trials and challenges – an interview with the California Institute for Regenerative Medicine
As part of our Spotlight on neuroregeneration, we spoke to Helen Budworth, Kent Fitzgerald and Kevin McCormack from the CIRM.
In this review, the authors discuss the challenges associated with neural regeneration and review the progress of stem cell-based regenerative medicine.
The California Institute for Regenerative Medicine (CIRM) announces that it is investing $15.9 million in a therapy to tackle ALS.
Commercializing regenerative medicine in the early days of a revolution: an interview with Mahendra Rao
In this interview, Mahendra Rao, co-founder, Q Therapeutics, discusses why these are the early days of a regenerative medicine revolution.
Cedric Bardy discusses progresses in stem cell reprogramming technologies that have the potential to lead to the discovery of new clinical treatments for neurological and psychiatric disorders.
A project aimed at helping people who have had a stroke, is among the programs approved today by the governing Board of CIRM.